Drug Trial Radar · NCT04368806
A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis
Last checked: Nov 19, 2026Latest source record: Aug 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
173
Actual
Start
May 26, 2021
Primary completion
Aug 6, 2027
Study completion Aug 7, 2027
Sponsor
- Lead sponsor
- Nature Cell Co. Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 30, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a double-blind, randomized, placebo controlled, multi-center, superiority study to evaluate the efficacy and safety of JointStem, autologous adipose tissue derived mesenchymal stem cells (AdMSC), in patients diagnosed as knee osteoarthritis. Following a 2-week screening period, approximately 140 subjects will be randomly assigned into one of the following two arms in a 1:1 ratio (1 JointStem : 1 Placebo). After each subject completes 48-Weeks visit (Visit 8) and the data management team confirms all individual data have no issue, the individual database will be locked and the blinding will be open for the statistical analysis.
Conditions
- Osteoarthritis, Knee
Interventions
JointStemDrug
Autologous Adipose tissue derived Mesenchymal Stem Cells (AdMSC)
Placebo ControlOther
Normal Saline with autologous Serum
Primary outcomes
What the sponsor says the trial is designed to measure.
- Western Ontario and McMaster Universities Arthritis Index (WOMAC) function ScoreTime frame: Baseline and Week 48
- Visual Analog Scale (VAS) scoreTime frame: Baseline and Week 48
Locations
9 sites in 2 countries. Site status is shown where the registry gives one.
TriWest Research Associates
El Cajon, California
BioSolutions Clinical Research Center
La Mesa, California
Neurovations Research
Napa, California
Newport Therapeutics
Newport Beach, California
Source Healthcare
Santa Monica, California
Keimyung University Dongsan Hospital
Daegu, Korea, South Korea
Kyung Hee University Medical Center
Seoul, Korea, South Korea
Kyung Hee University Hospital At Gangdong
Seoul, Korea, South Korea
Smg-Snu Boramae Medical Center
Seoul, Korea, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.